- Home
- PBYI vs KLTR Comparison
PBYI vs KLTR Comparison
Compare PBYI & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- KLTR
- Stock Information
- Founded
- PBYI 2010
- KLTR 2006
- Country
- PBYI United States
- KLTR United States
- Employees
- PBYI N/A
- KLTR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- KLTR EDP Services
- Sector
- PBYI Health Care
- KLTR Technology
- Exchange
- PBYI Nasdaq
- KLTR Nasdaq
- Market Cap
- PBYI 176.1M
- KLTR 177.3M
- IPO Year
- PBYI N/A
- KLTR 2021
- Fundamental
- Price
- PBYI $2.50
- KLTR $1.24
- Analyst Decision
- PBYI Strong Buy
- KLTR Buy
- Analyst Count
- PBYI 1
- KLTR 3
- Target Price
- PBYI $7.00
- KLTR $2.67
- AVG Volume (30 Days)
- PBYI 330.8K
- KLTR 100.2K
- Earning Date
- PBYI 10-31-2024
- KLTR 11-06-2024
- Dividend Yield
- PBYI N/A
- KLTR N/A
- EPS Growth
- PBYI N/A
- KLTR N/A
- EPS
- PBYI 0.18
- KLTR N/A
- Revenue
- PBYI $219,143,000.00
- KLTR $176,832,000.00
- Revenue This Year
- PBYI N/A
- KLTR $2.29
- Revenue Next Year
- PBYI N/A
- KLTR $2.32
- P/E Ratio
- PBYI $13.95
- KLTR N/A
- Revenue Growth
- PBYI N/A
- KLTR 2.65
- 52 Week Low
- PBYI $2.13
- KLTR $0.76
- 52 Week High
- PBYI $7.73
- KLTR $2.03
- Technical
- Relative Strength Index (RSI)
- PBYI 42.87
- KLTR 51.43
- Support Level
- PBYI $2.45
- KLTR $1.18
- Resistance Level
- PBYI $2.63
- KLTR $1.32
- Average True Range (ATR)
- PBYI 0.14
- KLTR 0.09
- MACD
- PBYI 0.06
- KLTR 0.01
- Stochastic Oscillator
- PBYI 65.85
- KLTR 55.38
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.